These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35091234)

  • 21. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.
    Kim JS; Kim MS; Park HJ; Jin SJ; Lee S; Hwang SJ
    Int J Pharm; 2008 Jul; 359(1-2):211-9. PubMed ID: 18501538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of antisolvent crystallization of sodium scutellarein by combined FBRM-PVM-NIR.
    Liu X; Sun D; Wang F; Wu Y; Chen Y; Wang L
    J Pharm Sci; 2011 Jun; 100(6):2452-9. PubMed ID: 21246557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of different cavitational reactors for size reduction of DADPS.
    Sabnis SS; Raikar R; Gogate PR
    Ultrason Sonochem; 2020 Dec; 69():105276. PubMed ID: 32739733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y; Ng WK; Hu J; Shen S; Tan RB
    Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound assisted intensified recovery of lactose from whey based on antisolvent crystallization.
    Gajendragadkar CN; Gogate PR
    Ultrason Sonochem; 2017 Sep; 38():754-765. PubMed ID: 27617771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal Habits of Itraconazole Microcrystals: Unusual Isomorphic Intergrowths Induced via Tuning Recrystallization Conditions.
    Mugheirbi NA; Tajber L
    Mol Pharm; 2015 Sep; 12(9):3468-78. PubMed ID: 26275018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallization of progesterone for pulmonary drug delivery.
    Ragab D; Rohani S; Samaha MW; El-Khawas FM; El-Maradny HA
    J Pharm Sci; 2010 Mar; 99(3):1123-37. PubMed ID: 19691108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Process intensification of atorvastatin calcium crystallization for target polymorph development via continuous combined cooling and antisolvent crystallization using an oscillatory baffled crystallizer.
    Kshirsagar S; Lakshmi Ramana Susarla N; Ramakrishnan S; Nagy ZK
    Int J Pharm; 2022 Nov; 627():122172. PubMed ID: 36084877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth and size control in anti-solvent crystallization of glycine with high frequency ultrasound.
    Nii S; Takayanagi S
    Ultrason Sonochem; 2014 May; 21(3):1182-6. PubMed ID: 24373692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sonocrystallization: effect on lactose recovery and crystal habit.
    Bund RK; Pandit AB
    Ultrason Sonochem; 2007 Feb; 14(2):143-52. PubMed ID: 16904362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability.
    Aucamp M; Odendaal R; Liebenberg W; Hamman J
    Drug Dev Ind Pharm; 2015; 41(7):1100-8. PubMed ID: 24980913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of niflumic acid prepared by rapid microwave-assisted evaporation.
    Radacsi N; Stefanidis GD; Szabó-Révész P; Ambrus R
    J Pharm Biomed Anal; 2014 Sep; 98():16-21. PubMed ID: 24873734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of high pressure homogenization on physicochemical properties of curcumin nanoparticles prepared by antisolvent crystallization using HPMC or PVP.
    Homayouni A; Sohrabi M; Amini M; Varshosaz J; Nokhodchi A
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():185-196. PubMed ID: 30813018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous synthesis of drug nanocrystals by solid hollow fiber cooling crystallization.
    Liu Q; Zhu X; Wang B; Zhou X; Liu C; Gao X; Sirkar KK; Chen D
    Int J Pharm; 2020 Feb; 576():118978. PubMed ID: 31870959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.